Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Viral Hepatitis|February 16, 2006
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markersC d'Arondel, M Munteanu, J Moussalli, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2007
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological featuresP Mathurin, F Beuzin, A Louvet, et al.
Journal of Hepatology|August 1, 1988
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trialD Lebrec, T Poynard, J P Capron, et al.
La Nouvelle Presse Medicale|April 11, 1981
[Follow-up of alcoholic patients in a hepatogastroenterology unit. Preliminary results (author's transl)]D Labayle, J P Dejonghe, L Papoz, et al.
Digestion|January 1, 1977
Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter studyA Gerolami, H Sarles, R Brette, et al.
Gastroenterology|June 1, 1996
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneP Mathurin, V Duchatelle, M J Ramond, et al.
Journal of Hepatology|August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 GroupF Degos, V Daurat, S Chevret, et al.
Journal of Hepatology|November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 GroupS Naveau, A Balian, F Degos, et al.
Gastroenterologie Clinique Et Biologique|April 25, 2001
[Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study]S Naveau, V Giraud, N Ganne, et al.
European Journal of Gastroenterology & Hepatology|August 13, 1999
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal HypertensionP Calés, F Oberti, J L Payen, et al.
Pageof 12